Wyeth Investors Win Class Cert. In Suit Over Pristiq Risks

Law360, New York (September 18, 2012, 4:51 PM EDT) -- A New York federal judge on Tuesday granted class certification to a group of investors accusing Pfizer Inc. unit Wyeth Pharmaceuticals Inc. of failing to disclose serious side effects associated with the antidepressant Pristiq.

The order comes four months after U.S. District  Judge Richard S. Sullivan indicated in a hearing that he would certify the class, which is led by a pipe fitters union and alleges that Wyeth, as an independent company in 2006, committed securities fraud by failing to disclose heart- and liver-related side effects...
To view the full article, register now.